The first-line treatment for psychotic disorders remains antipsychotic drugs with receptor
antagonist properties at D2-like dopamine receptors. However, long-term administration of …

The neurotransmitter histamine receives less attention compared with other biogenic
amines, because of its moderate action in the central nervous system (CNS). However …

Subcortical ischemic vascular dementia (SIVD) caused by chronic cerebral hypoperfusion
develops with progressive white matter and cognitive impairments, yet no effective therapy is …

Previously, we showed that carnosine upregulated the expression level of glutamate
transporter 1 (GLT-1), which has been recognized as an important participant in the …

Aims Epileptic seizures are well‐known neurological complications following stroke,
occurring in 3% of patients. However, the intrinsic correlation of seizures with stroke remains …

Reduction of glutamine synthetase (GS) function is closely related to established epilepsy,
but little is known regarding its role in epileptogenesis. The present study aimed to elucidate …

Tourette syndrome (TS) is caused by complex genetic and environmental factors and is
characterized by tics. Histidine decarboxylase (HDC) mutation is a rare genetic cause with …

Gender differences are involved in many neurological disorders including epilepsy.
However, little is known about the effect of gender difference on the risk of epilepsy in adults …

Histamine, a neurotransmitter or neuromodulator has been demonstrated to be
neuroprotective in cerebral ischemia. However, few reports concern its function on …

Subcortical ischemic vascular dementia caused by chronic cerebral hypoperfusion due to
small-artery disease is a common subtype of vascular dementia, which is recognized as the …